- Home
- SMLR vs CRVO Comparison
SMLR vs CRVO Comparison
Compare SMLR & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMLR
- CRVO
- Stock Information
- Founded
- SMLR 2007
- CRVO 2001
- Country
- SMLR United States
- CRVO United States
- Employees
- SMLR N/A
- CRVO N/A
- Industry
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SMLR Health Care
- CRVO Health Care
- Exchange
- SMLR Nasdaq
- CRVO Nasdaq
- Market Cap
- SMLR 289.5M
- CRVO 160.4M
- IPO Year
- SMLR 2014
- CRVO N/A
- Fundamental
- Price
- SMLR $54.26
- CRVO $11.96
- Analyst Decision
- SMLR
- CRVO Strong Buy
- Analyst Count
- SMLR 0
- CRVO 5
- Target Price
- SMLR N/A
- CRVO $57.60
- AVG Volume (30 Days)
- SMLR 317.4K
- CRVO 71.2K
- Earning Date
- SMLR 11-04-2024
- CRVO 11-19-2024
- Dividend Yield
- SMLR N/A
- CRVO N/A
- EPS Growth
- SMLR N/A
- CRVO N/A
- EPS
- SMLR 2.04
- CRVO N/A
- Revenue
- SMLR $58,938,000.00
- CRVO $9,653,281.00
- Revenue This Year
- SMLR N/A
- CRVO $54.54
- Revenue Next Year
- SMLR N/A
- CRVO N/A
- P/E Ratio
- SMLR $19.55
- CRVO N/A
- Revenue Growth
- SMLR N/A
- CRVO 585.67
- 52 Week Low
- SMLR $20.88
- CRVO $5.85
- 52 Week High
- SMLR $54.43
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- SMLR 83.35
- CRVO 41.25
- Support Level
- SMLR $36.23
- CRVO $11.95
- Resistance Level
- SMLR $44.52
- CRVO $12.82
- Average True Range (ATR)
- SMLR 3.98
- CRVO 1.07
- MACD
- SMLR 2.33
- CRVO -0.03
- Stochastic Oscillator
- SMLR 91.79
- CRVO 15.41
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.